(3S)-N-Boc-3-amino-β-phenylalanine-L-valine-(4S)-methylsuccinimide | 532393-80-9

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: (3S)-N-Boc-3-amino-β-phenylalanine-L-valine-(4S)-methylsuccinimide
• 英文别名: ((S)-2-{(S)-2-methyl-1-[1-((3R,4S)-4-methyl-2,5-dioxo-pyrrolidin-3-yl)-methanoyl]-propyl-carbamoyl}-1-phenyl-ethyl)-carbamic acid tert-butyl ester；tert-butyl N-[(1S)-3-[[(2S)-3-methyl-1-[(3R,4S)-4-methyl-2,5-dioxopyrrolidin-3-yl]-1-oxobutan-2-yl]amino]-3-oxo-1-phenylpropyl]carbamate
• CAS: 532393-80-9
• 化学式: C₂₄H₃₃N₃O₆
• 分子量: 459.543
• InChiKey: XSNPJRYSPZWVGR-WQCNXYOZSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  33
• 可旋转键数：
  10
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.54
• 拓扑面积：
  131
• 氢给体数：
  3
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  (3S)-N-Boc-3-amino-β-phenylalanine-L-valine-(4S)-methylsuccinimide 在 盐酸 作用下， 以 1,4-二氧六环 为溶剂， 生成 (3S)-β-phenylalanine-L-valine-(4S)-methylsuccinimide
  参考文献：
  名称：

  Pyrrolidinedione derivatives as antibacterial agents with a novel mode of action

  摘要：

  The pseudopeptide pyrrolidinedione natural products moiramide B and andrimid represent a new class of antibiotics that target bacterial fatty acid biosynthesis. Structure activity relationship (SAR) studies revealed a high degree of variability for the fatty acid side chain, allowing optimization of physicochemical parameters, and a restricted SAR for the pyrrolidinedione group, indicating major relevance of this subunit for efficient target binding. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2004.12.002
• 作为产物：
  描述：

  (S)-methylsuccinic anhydride 在 4-二甲氨基吡啶 、 三异丙基硅烷 、 palladium 10% on activated carbon 、 氢气 、 三乙胺 、 N,N-二异丙基乙胺 、 2-溴苯乙酮 、 N,N'-羰基二咪唑 、 N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate 作用下， 以 四氢呋喃 、 甲醇 、 二氯甲烷 、 N,N-二甲基甲酰胺 、 乙腈 为溶剂， 反应 9.5h， 生成 (3S)-N-Boc-3-amino-β-phenylalanine-L-valine-(4S)-methylsuccinimide
  参考文献：
  名称：

  山梨酸尾部对 Moiramide B 抗菌和抗结核特性作用的再研究

  摘要：

  新子口袋：在这项研究中，我们证明了假肽 moiramide B 的山梨酸尾部对于乙酰辅酶 A 羧化酶结合是必不可少的。基于结构-活性和分子建模数据，为 N-末端修饰的莫拉酰胺衍生物开发了结合模型。

  DOI：

  10.1002/cmdc.202200631

文献信息

• [DE] SUBSTITUIERTE ALKYLAMIDE<br/>[EN] SUBSTITUTED ALKYLAMIDES<br/>[FR] ALKYLAMIDES SUBSTITUES
  申请人：BAYER HEALTHCARE AG

  公开号：WO2004113290A1

  公开（公告）日：2004-12-29

  Die vorliegende Erfindung betrifft Verbindungen, Verfahren zur ihrer Herstellung, sie umfassende pharmazeutische Zusammensetzungen sowie ihre Verwendung bei der Behandlung und/oder Prophylaxe von Erkrankungen bei Menschen oder Tieren, insbesondere bakteriellen Infektionskrankheiten (Formula I).

  本发明涉及连接件、其制备方法、包含它们的药用组合物以及它们在治疗和/或预防人类或动物疾病，特别是细菌感染疾病（Formula I）中的应用。
• [DE] ARYLAMIDE<br/>[EN] ARYLAMIDES<br/>[FR] ARYLAMIDES
  申请人：BAYER HEALTHCARE AG

  公开号：WO2004020432A1

  公开（公告）日：2004-03-11

  Die vorliegende Erfindung betrifft Verbindungen der Formel,(I), Verfahren zur ihrer Herstellung, sie umfassende pharmazeutische Zusammensetzungen sowie ihre Verwendung bei der Behandlung und/oder Prophylaxe von Erkrankungen bei Menschen oder Tieren, insbesondere bakteriellen Infektionskrankheiten.

  本发明涉及公式(I)的化合物，其制备方法，包括它们的药用组合物以及它们在治疗和/或预防人类或动物疾病，特别是细菌感染疾病方面的用途。
• Cinnamic acid amides
  申请人：Brunner Nina

  公开号：US20090149528A1

  公开（公告）日：2009-06-11

  The present invention relates to compounds, to processes for preparing them, to pharmaceutical compositions comprising them, and to their use in the therapy and/or prophylaxis in illnesses in people or animals, especially diseases of bacterial infection.

  本发明涉及化合物、制备它们的方法、包含它们的制药组合物以及它们在治疗和/或预防人或动物疾病中的使用，特别是细菌感染疾病。
• Design, Synthesis, and Antibacterial Properties of Dual-Ligand Inhibitors of Acetyl-CoA Carboxylase
  作者：Molly A. Silvers、Gregory T. Robertson、Carol M. Taylor、Grover L. Waldrop

  DOI：10.1021/jm501082n

  日期：2014.11.13

  There is an urgent demand for the development of new antibiotics due to the increase in drug-resistant pathogenic bacteria. A novel target is the multifunctional enzyme acetyl-CoA carboxylase (ACC), which catalyzes the first committed step in fatty acid synthesis and consists of two enzymes: biotin carboxylase and carboxyltransferase. Covalently attaching known inhibitors against these enzymes with saturated hydrocarbon linkers of different lengths generated dual-ligand inhibitors. Kinetic results revealed that the dual-ligands inhibited the ACC complex in the nanomolar range. Microbiology assays showed that the dual-ligand with a 15-carbon linker did not exhibit any antibacterial activity, while the dual-ligand with a 7-carbon linker displayed broad-spectrum antibacterial activity as well as a decreased susceptibility in the development of bacterial resistance. These results suggest that the properties of the linker are vital for antibacterial activity and show how inhibiting two different enzymes with the same compound increases the overall potency while also impeding the development of resistance.
• Pyrrolidinedione derivatives as antibacterial agents with a novel mode of action
  作者：Jens Pohlmann、Thomas Lampe、Mitsuyuki Shimada、Peter G. Nell、Josef Pernerstorfer、Niels Svenstrup、Nina A. Brunner、Guido Schiffer、Christoph Freiberg

  DOI：10.1016/j.bmcl.2004.12.002

  日期：2005.2

  The pseudopeptide pyrrolidinedione natural products moiramide B and andrimid represent a new class of antibiotics that target bacterial fatty acid biosynthesis. Structure activity relationship (SAR) studies revealed a high degree of variability for the fatty acid side chain, allowing optimization of physicochemical parameters, and a restricted SAR for the pyrrolidinedione group, indicating major relevance of this subunit for efficient target binding. (C) 2004 Elsevier Ltd. All rights reserved.